Royal Philips (NYSE: PHG; AEX: PHIA) and Qualcomm Incorporated (NASDAQ: QCOM) through its subsidiary, Qualcomm Life, Inc., have announced a strategic technology collaboration to advance connected health across the health continuum - from healthy living and prevention to chronic care management and home care.
The U.S. Food and Drug Administration has announced the 2016 Naloxone App Competition, a public contest focused on developing innovative technologies to combat the rising epidemic of opioid overdose. The FDA, with support from the National Institute on Drug Abuse (NIDA) and the Substance Abuse and Mental Health Services Administration (SAMHSA), is inviting computer programmers, public health advocates, clinical researchers, entrepreneurs and innovators from all disciplines to
1 - 2 November 2016, Birmingham, UK.
Royal Philips (NYSE: PHG, AEX: PHIA) has unveiled its latest innovation in interventional oncology at the 2016 Cardiovascular and Interventional Radiological Society of Europe annual meeting (CIRSE 2016), which was held in Barcelona (Spain) from September 10 until 14. Philips' next generation interventional oncology solution OncoSuite will enable physicians to provide analysis and minimally invasive, targeted treatment of tumor lesions reducing the impact to healthy tissue.